Press Releases
5 November 2019
COLUMBIA, S.C., Nov. 5, 2019 /PRNewswire/ -- Open enrollment for the Health Insurance Marketplace in South Carolina runs from Nov. 1 through Dec. 15. This year,
Read more...5 November 2019
SILVER SPRING, Md., Nov. 5, 2019 /PRNewswire/ -- Today, the U.S. Food and Drug Administration authorized marketing of a test to detect human i
Read more...5 November 2019
ATLANTA, Nov. 5, 2019 /PRNewswire/ -- Open enrollment for the Health Insurance Marketplace in Georgia runs from Nov. 1 through Dec. 15. This year,
Read more...5 November 2019
CHICAGO, Nov. 5, 2019 /PRNewswire/ -- Beginning Nov. 1 through Dec. 15, Illinois residents may select Amb
Read more...5 November 2019
RESTON, Va., Nov. 5, 2019 /PRNewswire/ -- Amen Clinics Washington, D.C. is now offering several different type
Read more...5 November 2019
VANCOUVER, British Columbia, Nov. 5, 2019 /PRNewswire/ -- Core One Labs Inc. (CSE: COOL), (OTCQX: CLABF), (Frankfurt: LD6, WKN: A14XHT) ("COOL" or the "Company") is issuing this news release to clarify the terms of its definitive agreement to acquire Rainy Daze Cannabis, which was announced on November 4, 201
Read more...5 November 2019
CINCINNATI, Nov. 5, 2019 /PRNewswire/ -- Patient engagement pioneer and 30-year point-of-care marketing leader PatientPoint® dominated the 2019
Read more...5 November 2019
LARGO, Fla., Nov. 5, 2019 /PRNewswire/ -- Men's Liberty™ is sharing the top tips from their users after a diabetes diagnosis and the preferred solution to
Read more...5 November 2019
NEW YORK, Nov. 5, 2019 /PRNewswire/ -- Montefiore Medicine's Board of Trustees announced today that Dr. Philip O. Ozuah has been named the next Chief Executive Officer of Montefiore Medicine, the umbrella organization for Montefiore Health System (MHS) and Albert Einstein College of Medicine. As CEO, Dr. Ozuah will lead Montefiore Medicine's next phase of growth and evol
Read more...5 November 2019
LAS VEGAS and MARLBOROUGH, Mass., Nov. 5, 2019 /PRNewswire/ -- Today, Boston Scientific (NYSE: BSX) announced positive data for two devices within the peripheral drug-eluting product portfolio during separate late-breaking clinical trial presentations at Vascular InterVentional Advances (VIVA) meeting in Las Vega
Read more...